Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study
Article in Value in Health (March 2024)
The most recent citing publications are shown below. View all 47 publications that cite this research output on Dimensions.
Article in Value in Health (March 2024)
Article in Pathology - Research and Practice (February 2024)
Preprint in medRxiv (January 2024)